Novel non-peptidic opioid compounds with immunopotentiating effects

Advances in Experimental Medicine and Biology

Volumn 437, Issue , 1998, Pages 183-187

  Riley, Mary E ^a   Ananthan, Subramaniam ^b   Weber, Richard J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 BENZYLIDENENALTREXONE; CONCANAVALIN A; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; IMMUNOMODULATING AGENT; INTERLEUKIN 2; NALTREXONE; OPIATE DERIVATIVE;

ANIMAL CELL; CELL VIABILITY; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOPOTENTIATION; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; THYMOCYTE;

ANIMALIA;

EID: 0031852110     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-5347-2_20     Document Type: Conference Paper

References (24)

1. Weber, R. J. and A. Pert. 1989. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188.
2. Sibinga, N. E. and A. Goldstein. 1988. Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 6:219.
3. Carr, D. J. J., T. J. Rogers, and R. J. Weber. 1996. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc Soc Exp Biol Med 213:248.
4. Shavit, Y., A. Depaulis, F. C. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale, and J. C. Liebeskind. 1986. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U. S. A. 83:7114.
5. Sharp, B. M., N. A. Shahabi, W. Heagy, K. McAllen, M. Bell, C. Huntoon, and D. J. McKean. 1996. Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc. Natl. Acad. Sci. U. S. A. 93:8294.
6. Carr, D. J., B. R. Decosta, C. H. Kim, A. E. Jacobson, V. Guarcello, K. C. Rice, and J. E. Blalock. 1989. Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol 122:161.
7. Bidlack, J. M., L. D. Saripalli, and D. M. P. Lawrence. 1992. K-Opioid binding sites on a murine lymphoma cell line. Eur J Pharmacol 227:257.
8. Madden, J. J., R. M. Donahoe, J. Zwemer-Collins, D. A. Shafer, and A. Falek. 1987. Binding of naloxone to human T lymphocytes. Biochem Pharmacol 36:4103.
9. Carr, D. J., C. H. Kim, B. deCosta, A. E. Jacobson, K. C. Rice, and J. E. Blalock. 1988. Evidence for a delta-class opioid receptor on cells of the immune system. Cell Immunol. 116:44.
10. Chuang, L. F., T. K. Chuang, K. F. Killam, Jr., A. J. Chuang, H. F. Kung, L. Yu, and R. Y. Chuang. 1994. Delta opioid receptor gene expression in lymphocytes. Biochem. Biophys. Res Commun. 202:1291.
11. Lawrence, D. M., W. el-Hamouly, S. Archer, J. F. Leary, and J. M. Bidlack. 1995. Identification of kappa opioid receptors in the immune system by indirect immunofluorescence. Proc Natl Acad Sci USA 92:1062.
12. Carr, D. J. 1991. The role of endogenous opioids and their receptors in the immune system. Proc Soc Exp Biol Med 198:710.
13. Bryant, H. U., E. W. Bernton, and J. W. Holaday. 1987. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci 41:1731.
14. Linner, K. M., H. E. Quist, and B. M. Sharp. 1995. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J Immunol 154:5049.
15. Carr, D. J. and G. R. Klimpel. 1986. Enhancement of the generation of cytotoxic T cells by endogenous opiates. J Neuroimmunol 12:75.
16. Mandler, R. N., W. E. Biddison, R. Mandler, and S. A. Serrate. 1986. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 136:934.
17. Pert, C. B., M. R. Ruff, R. J. Weber, and M. Herkenham. 1985. Neuropeptides and their receptors: a psychosomatic network. J Immunol 135:820s.
18. Sanchez, S. R., K. C. Rice, S. N. Calderon, M. E. Riley, and R. J. Weber. 1996. Receptor-Mediated Enhancement of In Vitro Lymphocyte Proliferation by Novel d-Selective Opioid Ligands. NIDA Res Monogr 106.
19. Wybran, J., T. Appelboom, J. P. Famaey, and A. Govaerts. 1979. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol 123:1068.
20. Arakawa, K., T. Akami, M. Okamoto, K. Akioka, I. Nakai, T. Oka, and H. Nagase. 1993. Immunosuppression by delta opioid receptor antagonist. Transplant Proc 25:738.
21. Portoghese, P. S. 1993. The design of delta-selective opioid receptor antagonists. Il Farmaco 48:243.
22. House, R. V., P. T. Thomas, J. T. Kozak, and H. N. Bhargava. 1995. Suppression of immune function by non-peptidic delta opioid receptor antagonists. Neurosci Lett 198:119.
23. Ananthan, S., C. A. Johnson, F. Porreca, P. Davis, K. C. Rice, H. Xuand, and R. B. Rothman. 1996. Abstract MEDI-158. (Abstract)
24. Linner, K. M., S. E. Nicol, and B. M. Sharp. 1993. IL-1 beta modulates the concanavalin-A-induced expression of proenkephalin A mRNA in murine thymocytes. J Pharmacol Exp Ther 267:1566.